Publications by authors named "Melinda M Rottas"
Article Synopsis
- The study addresses the importance of diversity in clinical trials (CTs) to improve health equity and ensure that findings are applicable to diverse populations.
- An advisory board of experts was formed to create a framework for setting enrollment goals that incorporates data from various sources, including the US Census and real-world data.
- The resulting framework aims to establish transparent, reproducible enrollment goals while highlighting ethical considerations and addressing limitations related to underrepresented groups in medical research.
A novel alpha 7 nAChR agonist, 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (24, CP-810,123), has been identified as a potential treatment for cognitive deficits associated with psychiatric or neurological conditions including schizophrenia and Alzheimer's disease.
View Article and Find Full Text PDF